Figure 2:

Cataract-free survival by Total Points Group, among eyes with anterior uveitis from the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. At 5 years, the estimated cumulative incidence of cataract was approximately 6% for risk points 0 to 2; 14% for risk points 3 to 4, and 38% for risk points≥5. At 15 years, the estimated cumulative incidence of cataract was approximately 12% for risk points 0 to 2; 24% for risk points 3 to 4, and 55% for risk points≥5.